Amphastar Pharmaceuticals AMPH
$ 45.51
2.14%
Quarterly report 2024-Q3
added 11-07-2024
Amphastar Pharmaceuticals Retained Earnings 2011-2024 | AMPH
Annual Retained Earnings Amphastar Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
409 M | 272 M | 180 M | 118 M | 116 M | 67.5 M | 76.2 M | 70.9 M | 60.3 M | 63.1 M | 73.8 M | 61.9 M | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
409 M | 60.3 M | 131 M |
Quarterly Retained Earnings Amphastar Pharmaceuticals
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
531 M | 490 M | 409 M | 373 M | - | 298 M | 272 M | - | 222 M | 205 M | 180 M | 161 M | 131 M | 123 M | 118 M | 118 M | 118 M | 118 M | 116 M | 116 M | 116 M | 116 M | 67.5 M | 67.5 M | 67.5 M | 67.5 M | 72.6 M | 72.6 M | 76.2 M | 76.2 M | 70.9 M | 70.9 M | 70.9 M | 70.9 M | 60.3 M | 60.3 M | 60.3 M | 60.3 M | 63.1 M | 63.1 M | 63.1 M | 63.1 M | 73.8 M | 73.8 M | 73.8 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
531 M | 60.3 M | 137 M |